Peripheral cytokine expression in autoimmune thyroiditis: Effects of in vitro modulation by rosiglitazone and dexamethasone

Thyroid

Volumn 16, Issue 10, 2006, Pages 953-960

  Okosieme, O E ^a   Parkes, A B ^a   Premawardhana, L D K E ^a   Thomas, A W ^b   Evans, L M ^a   Lazarus, J H ^a  

^a CARDIFF UNIVERSITY   (United Kingdom)

^b CARDIFF METROPOLITAN UNIVERSITY   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

CD8 ANTIGEN; CYTOKINE; DEXAMETHASONE; GAMMA INTERFERON; GLUCOCORTICOID; INTERLEUKIN 4; IONOMYCIN; PEROXISOME PROLIFERATOR ACTIVATED RECEPTOR GAMMA; PHORBOL 13 ACETATE 12 MYRISTATE; ROSIGLITAZONE;

ADULT; AGED; ARTICLE; AUTOIMMUNE THYROIDITIS; CD4 LYMPHOCYTE COUNT; CD4+ T LYMPHOCYTE; CD8+ T LYMPHOCYTE; CLINICAL ARTICLE; CONCENTRATION RESPONSE; CONTROLLED STUDY; DRUG EFFECT; FEMALE; FLOW CYTOMETRY; GENE EXPRESSION; HASHIMOTO DISEASE; HUMAN; HUMAN CELL; IMMUNE RESPONSE; IMMUNOMODULATION; IMMUNOREGULATION; IN VITRO STUDY; MALE; PERIPHERAL BLOOD MONONUCLEAR CELL; PERIPHERAL LYMPHOCYTE; PRIORITY JOURNAL; T LYMPHOCYTE ACTIVATION; TH1 CELL; TH2 CELL;

ADULT; AGED; CD4-POSITIVE T-LYMPHOCYTES; CD8-POSITIVE T-LYMPHOCYTES; CYTOKINES; DEXAMETHASONE; FEMALE; GENE EXPRESSION REGULATION; GLUCOCORTICOIDS; HASHIMOTO DISEASE; HUMANS; HYPOGLYCEMIC AGENTS; INTERFERON TYPE II; INTERLEUKIN-4; MALE; MIDDLE AGED; TETRADECANOYLPHORBOL ACETATE; THIAZOLIDINEDIONES; THYROIDITIS, AUTOIMMUNE;

EID: 33846451817     PISSN: 10507256     EISSN: None     Source Type: Journal    
DOI: 10.1089/thy.2006.16.953     Document Type: Article

References (39)

1. Weetman AP, McGregor AM 1994 Autoimmune thyroid disease: developments in our understanding. Endocr Rev 15:788-802.
2. Roura-Mir C, Catalfamo M, Sospedra M, Alcalde L, Pujol-Borrell, R Jaraquemada D 1997 Single-cell analysis of intrathyroidal lymphocytes shows differential cytokine expression in Hashimoto's and Graves' disease. Eur J Immunol 27:3290-3302.
3. Mazziotti G, Sorvillo F, Naclerio C, Farzati A, Cioffi M, Perna R, Valentini G, Farzati B, Amato G, Carella C 2003 Type-1 response in peripheral CD4+ and CD8+ T cells from patients with Hashimoto's thyroiditis. Eur J Endocrinol 148:383-388.
4. Issemann I, Green S 1998 Activation of a member of the steroid hormone receptor superfamily by peroxisome proliferators. Nature 347:645-650.
5. Lemberger T, Desvergne B, Wahli W 1996 Peroxisome proliferator-activated receptors: A nuclear receptor signaling pathway in lipid physiology. Annu Rev Cell Dev Biol 12:1355-1363.
6. Clark RB 2002 The role of PPARs in inflammation and immunity. J Leukoc Biol 71:388-400.
7. Clark RB, Bishop-Bailey D, Estrada-Hernandez T, Hla T, Puddington L, Padula SJ 2000 The nuclear receptor PPARγ and immunoregulation: PPARγ mediates inhibition of helper T cell responses. J Immunol 164:1364-1371.
8. Schmidt S, Moric E, Schmidt M, Sastre M, Feinstein DL, Heneka MT 2004 Anti-inflammatory and antiproliferative actions of PPAR-γ agonists on T lymphocytes derived from MS patients. J Leukoc Biol 75:478-485.
9. Marx N, Kehrle B, Kohlhammer K, Grub M, Koenig W, Hombach V, Libby P, Plutzky J 2002 PPAR activators as anti-inflammatory mediators in human T lymphocytes: Implications for atherosclerosis and transplantation-associated arteriosclerosis. Circ Res 90:703-710.
10. Niino M, Iwabuchi K, Kikuchi S, Ato M, Morohashi T, Ogata A, Tashiro K, Onoe K 2001 Amelioration of experimental autoimmune encephalomyelitis in C57BL/6 mice by an agonist of peroxisome proliferator-activated receptor γ. J Neuroimmunol 116:40-48.
11. H1 differentiation. Genes Immunol 3:59-70.
12. Blotta MH, DeKruyff RH, Umetsu DT 1997 Corticosteroids inhibit IL-12 production in human monocytes and enhance their capacity to induce IL-4 synthesis in CD4+ lymphocytes. J Immunol 158:5589-5595.
13. Visser J, van Boxel-Dezaire A, Methorst D, Brunt T, de Kloet ER, Nagelkerken L 1998 Differential regulation of interleukin-10 (IL-10) and IL-12 by glucocorticoids in vitro. Blood 91:4255-4264.
14. Krakauer T 1995 Differential inhibitory effects of interleukin-10, interleukin-4, and dexamethasone on staphylococcal enterotoxin-induced cytokine production and T cell activation. J Leukoc Biol 57:450-454.
15. Kota BP, Huang TH, Roufogalis BD 2005 An overview on biological mechanisms of PPARs. Pharmacol Res 51:85-94.
16. Ialenti A, Grassia G, Di Meglio P, Maffia P, Di Rosa M, Ianaro A 2005 Mechanism of the anti-inflammatory effect of thiazolidinediones: relationship with the glucocorticoid pathway. Mol Pharmacol 67:1620-1628.
17. Simoncini T, Genazzani AR 2003 Non-genomic actions of sex steroid hormones. Eur J Endocrinol 148:281-292.
18. Gardner OS, Dewar BJ, Graves LM 2005 Activation of mitogen-activated protein kinases by peroxisome proliferator-activated receptor ligands: An example of nongenomic signaling. Mol Pharmacol 68:933-941.
19. Groves CJ, Howells RD, Williams S, Darke C, Parkes AB 1990 Primary standardization for the ELISA of serum thyroperoxidase and thyroglobulin antibodies and their prevalence in a normal Welsh population. J Clin Lab Immunol 32:147-151.
20. Drugarin D, Negru S, Koreck A, Zosin I, Cristea C 2000 The pattern of a T(H)1 cytokine in autoimmune thyroiditis. Immunol Lett 71:73-77.
21. Malinowski JM, Bolesta S 2000 Rosiglitazone in the treatment of type 2 diabetes mellitus: a critical review. Clin Ther 22:1151-1168.
22. Furue M, Ishibashi Y 1991 Differential regulation by dexamethasone and cyclosporine of human T cells activated by various stimuli. Transplantation 52:522-526.
23. Jiang C, Ting AT, Seed B 1998 PPAR-gamma agonists inhibit production of monocyte inflammatory cytokines. Nature 391:82-86.
24. Yang XY, Wang LH, Chen T, Hodge DR, Resau JH, DaSilva L, Farrar WL 2000 Activation of human T lymphocytes is inhibited by peroxisome proliferator-activated receptor gamma (PPARgamma) agonists. PPARgamma co-association with transcription factor NFAT. J Biol Chem 275: 4541-4544.
25. Chawla A, Barak Y, Nagy L, Liao D, Tontonoz P, Evans RM 2001 PPAR-gamma dependent and independent effects on macrophage-gene expression in lipid metabolism and inflammation. Nat Med 7:48-52.
26. Davis RJ 1993 The mitogen-activated protein kinase signal transduction pathway. J Biol Chem 268:14553-14556.
27. Rokos CL, Ledwith BJ 1997 Peroxisome proliferators activate extracellular signal-regulated kinases in immortalized mouse liver cells. J Biol Chem 272:13452-13457.
28. Clark AR, Lasa M 2003 Crosstalk between glucocorticoids and mitogen-activated protein kinase signalling pathways. Curr Opin Pharmacol 3:404-411.
29. Nijhuis EWP, Hinloopen B, Odding J, Nagelkerken L 1994 Abrogation of the suppressive effects of dexamethasone by PKC activation or CD28 triggering. Cell Immunol 156: 438-447.
30. Hong G, Davis B, Khatoon N, Baker SF, Brown J 2003 PPAR gamma-dependent anti-inflammatory action of rosiglitazone in human monocytes: Suppression of TNF alpha secretion is not mediated by PTEN regulation. Biochem Biophys Res Commun 303:782-787.
31. Alleva DG, Johnson EB, Lio FM, Boehme SA, Conlon PJ, Crowe PD 2002 Regulation of murine macrophage proinflammatory and anti-inflammatory cytokines by ligands for peroxisome proliferator-activated receptor-gamma: Counter-regulatory activity by IFN-gamma. J Leukoc Biol 71:677-685.
32. Botella-Carretero JI, Prados A, Manzano L, Montero MT, Escribano L, Sancho J, Escobar-Morreale HF 2005 The effects of thyroid hormones on circulating markers of cell-mediated immune response, as studied in patients with differentiated thyroid carcinoma before and during thyroxine withdrawal. Eur J Endocrinol 153:223-230.
33. Karanikas G, John P, Wahl K, Schuetz M, Dudczak R, Willheim M 2004 T-lymphocyte cytokine production patterns in nonimmune severe hypothyroid state and after thyroid hormone replacement therapy. Thyroid 14:488-492.
34. Wilder RL 1995 Neuroendocrine-immune system interactions and autoimmunity. Annu Rev Immunol 13:307-338.
35. Schauenstein K, Fassler R, Dietrich H, Schwarz S, Kromer G, Wick G 1987 Disturbed immune-endocrine communication in autoimmune disease. Lack of corticosterone response to immune signals in obese strain chickens with spontaneous autoimmune thyroiditis. J Immunol 139: 1830-1833.
36. Kokandi AA, Parkes AB, Premawardhana LD, John R, Lazarus JH 2003 Association of postpartum thyroid dysfunction with antepartum hormonal and immunological changes. J Clin Endocrinol Metab 88:1126-1132.
37. Chikanza IC 2002 Mechanisms of corticosteroid resistance in rheumatoid arthritis: A putative role for the corticosteroid receptor beta isoform. Ann NY Acad Sci 966:39-48.
38. Sher ER, Leung DY, Surs W, Kam JC, Kamada AK, Szefler SJ 1994 Steroid-resistant asthma. Cellular mechanisms contributing to inadequate response to glucocorticoid therapy. J Clin Invest 93:133-139.
39. Antonelli A, Rotondi M, Ferrari SM, Fallahi P, Romagnani P, Franceschini SS, Serio M, Ferrannini E 2006 Interferon-gamma-inducible alpha-chemokine CXCL10 involvement in Graves' ophthalmopathy: modulation by peroxisome proliferator-activated receptor-gamma agonists. J Clin Endocrinol Metab 91:614-620.